期刊
JOURNAL OF NUCLEAR MEDICINE
卷 53, 期 8, 页码 1244-1252出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.112.109306
关键词
MRI; PET; PET/MRI; oncology
With integrated whole-body PET/MRI, a novel metabolic-anatomic imaging technique recently has been introduced into clinical practice. This review addresses PET/MRI of bone tumors, soft-tissue sarcoma, melanoma, and lymphoma. If PET/MRI literature is not yet available for some types of tumors, potential indications are based on available PET/CT and MRI data. PET/MRI seems to be of benefit in T-staging of primary bone tumors and soft-tissue sarcomas. With regard to N-staging, PET/MRI can be considered similarly accurate to PET/CT when applied as a whole-body staging approach. M-staging will benefit from MA) accuracy in the brain, the liver, and bone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据